Showing results (311-320 of 344) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2017
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell LymphomasSergio Cortelazzo, Corrado Tarella, Alessandro Massimo Gianni, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Cancer|March 22, 2025
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemiaCristina Papayannidis, Elisabetta Petracci, Patrizia Zappasodi, et al.
Haematologica|November 1, 2019
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trialRiccardo Bruna, Fabio Benedetti, Carola Boccomini, et al.
Blood|February 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Cancer|December 21, 2019
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosisFrancesca Palandri, Massimo Breccia, Massimiliano Bonifacio, et al.
Blood|August 4, 2026
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Noemi Puccio, Roberta Torcasio, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic LeukemiaRiccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia & Lymphoma|July 13, 2011
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patientsMichele Malagola, Cristina Skert, Marco Vignetti, et al.
Pageof 35